These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10788680)

  • 1. Paroxetine binding in aggressive schizophrenic patients.
    Modai I; Gibel A; Rauchverger B; Ritsner M; Klein E; Ben-Shachar D
    Psychiatry Res; 2000 Apr; 94(1):77-81. PubMed ID: 10788680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia.
    Maguire K; Cheung P; Crowley K; Norman T; Schweitzer I; Burrows G
    Schizophr Res; 1997 Jan; 23(1):61-7. PubMed ID: 9050129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
    Naylor L; Dean B; Opeskin K; Pavey G; Hill C; Keks N; Copolov D
    J Neural Transm (Vienna); 1996; 103(6):749-57. PubMed ID: 8836936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
    Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
    Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
    Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
    Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.
    Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B
    Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet serotonergic functions and light therapy in seasonal affective disorder.
    Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
    Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.
    Patkar AA; Gottheil E; Berrettini WH; Hill KP; Thornton CC; Weinstein SP
    Am J Addict; 2003; 12(5):432-47. PubMed ID: 14660157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.
    Jurado N; Torner C; Heinze G; López G; Mendoza-Sotelo J; Lazo-Langner A; Moreno J
    Arch Med Res; 2003; 34(5):422-7. PubMed ID: 14602510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
    Smedh K; Spigset O; Allard P; Mjörndal T; Adolfsson R
    Biol Psychiatry; 1999 Feb; 45(4):464-70. PubMed ID: 10071719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults.
    Sigurdh J; Spigset O; Allard P; Mjörndal T; Hägglöf B
    Neuropsychobiology; 1999 Nov; 40(4):183-7. PubMed ID: 10559700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine binding to blood platelets and aggressive behavior in offenders, schizophrenics and normal volunteers.
    Sarne Y; Mandel J; Goncalves MH; Brook S; Gafni M; Elizur A
    Neuropsychobiology; 1995; 31(3):120-4. PubMed ID: 7609859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
    Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
    Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.
    Urbina M; Pineda S; Piñango L; Carreira I; Lima L
    Int J Immunopharmacol; 1999 Oct; 21(10):631-46. PubMed ID: 12609459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet serotonergic binding sites in alcohol-dependent patients.
    Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
    Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
    Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
    Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.
    Jockers-Scherübl MC; Bauer A; Godemann F; Reischies FM; Selig F; Schlattmann P
    Int Clin Psychopharmacol; 2005 Jan; 20(1):27-31. PubMed ID: 15602113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.